Vaccine and Infectious Disease Division

Scientist with petri dish

Featured News from VIDD


The Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle

The annual Conference on Retroviruses and Opportunistic Infections (CROI) is taking place in Seattle, Washington the week of February 23-26, 2015. Established in 1993, CROI brings together over 4,000 participants from around the globe to inform, discuss and brainstorm about current and future directions to prevent the morbidity and mortality from HIV.  Read more >

More Featured News from VIDD >

Upcoming VIDD Events

Laura MacKay, PhD
Tuesday, April 7

Jeffrey McLean, PhD
Tuesday, April 14

VIDD Faculty Stories

Curing chronic viral infections with Keith Jerome
It wasn’t very long ago that the idea of an HIV cure was scoffed at. The concept of a curative method for dealing with chronic viral infections, as opposed to preventative (such as vaccines) or treatment (such as antivirals), has a history of controversy among the field.

More VIDD Faculty Stories >

VIDD Publication Spotlight

Off target effects of rectal tenofovir gel
The antiviral tenofovir is a widely used drug for HIV prevention and treatment as an oral pill. The Microbicides Trial Network (MTN) phase 1 clinical trial was designed to detect possible subtle yet important ‘off target’ effects from rectal 1% tenofovir gel formulation treatment.

More VIDD News >

Find VIDD Faculty

International Spotlight

Uganda offers a unique setting to study the impact of infections on the development and clinical course of several cancers.

More International Programs >>

VIDD Announcements

VIDD highlights promotions, new hires, honors/awards and goings of its faculty and staff.